Ann Dermatol.  2018 Feb;30(1):100-101. 10.5021/ad.2018.30.1.100.

A Case of Acute Generalized Exanthematous Pustulosis after Injection of an Erythropoiesis-Stimulating Agent

• Suh HY
• Bae J
• Kim HL
• Kim KH
• Cha RH
• Ahn JY
• Youn JI
• Park MY

• KMID: 2399766
• DOI: http://doi.org/10.5021/ad.2018.30.1.100

Abstract

No abstract available.

MeSH Terms

Acute Generalized Exanthematous Pustulosis*

Figure

• 

  Fig. 1 (A) Multiple miliary pustules on the neck and trunk. (B) A close-up view on the neck. (C) A close-up view on the chest.

• 

  Fig. 2 Subcorneal pustule with papillary edema and mixed inflammatory infiltrate of mainly neutrophils and eosinophils (H&E; A: ×100, B: ×200).

Reference

1. Del Vecchio L, Locatelli F. An overview on safety issues related to erythropoiesis-stimulating agents for the treatment of anaemia in patients with chronic kidney disease. Expert Opin Drug Saf. 2016; 15:1021–1030.

2. Halevy S. Acute generalized exanthematous pustulosis. Curr Opin Allergy Clin Immunol. 2009; 9:322–328.

3. Schmutz JL, Barbaud A, Trechot P. Epoetin alpha-induced acute generalized exanthematous pustulosis and desensitisation. Ann Dermatol Venereol. 2010; 137:761–762.

4. Hamdi NM, Al-Hababi FH, Eid AE. HLA class I and class II associations with ESRD in Saudi Arabian population. PLoS One. 2014; 9:e111403.

5. Casadevall N, Rossert J. Importance of biologic follow-ons: experience with EPO. Best Pract Res Clin Haematol. 2005; 18:381–387.